Onconetix, Inc. Warrant, Exercise Price, Decrease
Onconetix, Inc. (ONCO) reported Warrant, Exercise Price, Decrease of $54.50 per share for the 12-month period ending 2024-12-31, per its 10-K filed 2025-06-02.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:WarrantExercisePriceDecrease · last filed 2025-06-02
- Onconetix, Inc. warrant, exercise price, decrease for fiscal 2024 was $54.50.
- Onconetix, Inc. warrant, exercise price, decrease for fiscal 2022 was $6.65.
| Period end | Warrant, Exercise Price, Decrease 1 month | Warrant, Exercise Price, Decrease 6 month | Warrant, Exercise Price, Decrease 9 month | Warrant, Exercise Price, Decrease 12 month |
|---|---|---|---|---|
| 2024-12-31 | $54.50 10-K · filed 2025-06-02 | |||
| 2024-09-30 | $54.50 10-Q · filed 2024-12-10 | |||
| 2024-06-30 | $0.19 10-Q · filed 2024-08-29 | |||
| 2023-07-31 | $1.09 10-Q · filed 2023-11-17 | |||
| 2022-12-31 | $6.65 10-K · filed 2023-03-09 | |||
| 2022-04-19 | $6.65 10-Q · filed 2023-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |